CYTOPATHFINDER INC.
It all starts from focusing on patients - to help promote people’s health and quality of life. By using their expertise in cellular and clinical pharmacogenomics, they aim to develop more and better medicines, to help others develop medicines and to help doctors use medicines to treat patients more effectively. CytoPathfinder also pledges to play its part as a good corporate citizen by observing relevant corporate ethics guidelines and implementing health, safety, and environmental measures extensively.
CYTOPATHFINDER INC.
Industry:
Biotechnology Pharmaceutical
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.cytopathfinder.com
Status:
Active
Contact:
+81-3-3264-0780
Technology used in webpage:
SPF SSL By Default Apache AJAX Libraries API GlobalSign GlobalSign Seal NTT SmartConnect
Current Employees Featured
Official Site Inspections
http://www.cytopathfinder.com
- Host name: wx105.wadax-sv.jp
- IP address: 153.123.7.38
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "CytoPathfinder Inc."
Company Information - CytoPathfinder, Inc.
Oct 10, 2022 NEDO* grants subsidy to CytoPathfinder for the development of a Cellular Pharmacogenomics (PGx) system for profiling hepatotoxic compounds. (*New Energy and …See details»
CytoPathfinder, Inc.
CytoPathfinder ,Inc .is providing Products and Services based on the core technology , solid –phase Transfection ,developed by the National Institute of Science and Technology(AIST), …See details»
CytoPathfinder - Crunchbase Company Profile & Funding
Organization. CytoPathfinder . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... CytoPathfinder also pledges to play. its part as a good …See details»
会社概要 - 株式会社サイトパスファインダー
Oct 10, 2022 株式会社 サイトパスファインダー（CytoPathfinder, Inc. 略称：CP） 設立: 2004年12月20日 産総研技術移転ベンチャー企業として設立: 資本金: 1765万: 経営陣: 山本栁二（代 …See details»
Cytopathfinder, Inc. - Products, Competitors, Financials, Employees ...
Provider of transfection technology for facilitating target discovery and alternative pathway analysis. Use the CB Insights Platform to explore Cytopathfinder, Inc.'s full profile.See details»
CytoPathfinder, Inc.: Drug pipelines, Patents, Clinical trials - Synapse
Jul 16, 2023 Explore CytoPathfinder, Inc. with its drug pipeline, therapeutic area, technology platform, 4 literature, Technology Platform:Small molecule drug, Drug:PG-103 ...See details»
CytoPathfinder Inc. - Tech Stack, Apps, Patents & Trademarks
CytoPathfinder Inc. is a Biotechnology Company. Start Free Trial . Chrome ExtensionSee details»
CytoPathfinder Inc. - BioCentury Company Profiles - BCIQ
CytoPathfinder Inc. - BioCentury Company Profiles for the biopharma industrySee details»
CytoPathfinder - Craft
See insights on CytoPathfinder including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
BUSINESS CytoPathfinder, Inc.
We would like to introduce our main business activities. Production and sales of various nucleic acid solidification plates and research and development applying solid phase methodSee details»
CytoPathfinder - Overview, News & Competitors | ZoomInfo.com
CytoPathfinder - Business Information. Business Services · Japan · 25 Employees . It all starts from focusing on patients - to help promote people’s health and quality of life. By using their …See details»
CytoPathfinder - Contacts, Employees, Board Members, Advisors …
Organization. CytoPathfinder . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. CytoPathfinder has 1 …See details»
CytoPathfinder - Biotech Careers
SiRNA transfection Business Areas: RNA. Biotech-Careers is funded in part by the National Science FoundationSee details»
CONTACT US CytoPathfinder, Inc.
We welcome your inquiries about our company. Please feel free to contact us.See details»
Yuko Saito - President and CEO @ CytoPathfinder Inc. - Crunchbase
Primary Organization . CytoPathfinder Inc. Location Tokyo, Tokyo, Japan; Regions Asia-Pacific (APAC) Also Known As 山本柳二; Yuko Saito is the President and CEO at CytoPathfinder Inc. …See details»
CytoPathfinder, Santen to Do Joint Research for Ophthalmic Drugs
CytoPathfinder, Inc. (www.cytopathfinder.com) and Santen Pharmaceutical announced on March 22 that they have signed a three-year research agreement to jointly search for target …See details»
Qiagen and CytoPathfinder Combines Technologies in RNAi …
May 24, 2006 Qiagen and CytoPathfinder Combines Technologies in RNAi Screening. News . Published: May 24, 2006 Download Article ...See details»
Technology - CytoPathfinder, Inc.
CytoPathfinder’s breakthrough technology The innovative solid-phase transfection technology developed by Dr. Masato Miyake, a founding member of CytoPathfinder, dramatically boosts …See details»
株式会社サイトパスファインダーの会社情報と資金調達 | NIKKEI …
Feb 9, 2024 参天製薬 有価証券報告書 ‐ 第94期（平成17年4月1日 ‐ 平成18年3月31日）... 株式会社 サイトパスファインダー 社とは、 眼科疾患治療のための ...See details»
APPLICATION - CytoPathfinder, Inc.
Records for primary cells Other Application Records forSee details»